Living-Donor Liver Transplantation for a Large Hepatocellular Carcinoma in a Genetically Identical Twin Sister

Ger Koek,Sophia M. Schmitz,Jan Bednarsch,Daniel Heise,Thomas Longerich,Frank Bakers,Christian Trautwein,Tom Luedde,Tom Florian Ulmer,Ulf Peter Neumann

DOI: https://doi.org/10.1055/a-2214-1712

2024-01-11

Zeitschrift für Gastroenterologie

Abstract:Hepatocellular carcinoma (HCC) is, to date, the most common malignant tumor of the liver and is commonly staged with the Milan criteria. While deceased-donor liver transplantations (DDLT) are reserved for patients within the Milan criteria, living-donor liver transplantation (LDLT) might be a curative option for patients outside the Milan criteria. We here report a case of a 32-year-old woman who developed a giant, unresectable HCC out of a hepatocellular adenoma (HCA) after a pregnancy. The genetically identical twin sister donated her left hemi-liver after ethical approval and preoperative screening. No long-term immunosuppressive therapy was necessary, and after more than eight years, both are in perfect health and the recipient gave birth to a second child. This case shows that in certain situations large HCCs outside the standard criteria can be cured by LT. Careful evaluation of both donor and recipient should be performed for indications like this to assure optimal clinical outcome. Das Hepatozelluläre Karzinom (HCC) ist der häufigste bösartige Tumor der Leber und wird häufig anhand der Mailänder Kriterien klassifiziert. Lebertransplantationen verstorbener Spender (DDLT) sind Patienten vorbehalten, die sich innerhalb der Mailänder Kriterien befinden. Für Patienten außerhalb der Mailänder Kriterien können Lebertransplantation durch einen Lebendspender (LDLT) eine therapeutische Option sein. Diese Studie berichtet über den Fall einer 32-jährigen Frau, die nach einer Schwangerschaft ein riesiges, inoperables HCC aus einem hepatozellulären Adenom (HCA) entwickelte. Die genetisch identische Zwillingsschwester spendete nach ethischer Genehmigung und präoperativem Screening ihre linke Leberhälfte. Eine langfristige immunsuppressive Therapie war nicht erforderlich. Mehr als acht Jahre nach der Transplantation sind beide Schwestern gesundheitlich in exzellentem Zustand und die Empfängerin brachte kürzlich ein zweites Kind zur Welt. Dieser Fall zeigt, dass in bestimmten Situationen große HCCs außerhalb der Mailänder Kriterien durch Leber-Lebendspenden geheilt werden können. Bei solchen Indikationen muss eine sorgfältige Beurteilung sowohl des Spenders als auch des Empfängers durchgeführt werden, um ein optimales klinisches Ergebnis sicherzustellen. Received: 31 August 2023 Article published online: 09 January 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

gastroenterology & hepatology

What problem does this paper attempt to address?

The paper primarily discusses a case of living donor liver transplantation (LDLT) under special circumstances, aiming to address the issue of a 32-year-old female patient with a massive hepatocellular carcinoma (HCC). The size of the patient's tumor exceeded the Milan criteria, thus disqualifying her from traditional deceased donor liver transplantation (DDLT). Specifically:

1. **Patient Background**: The patient was diagnosed with a large, unresectable hepatocellular adenoma (HCA) that transformed into HCC after pregnancy. The tumor had a diameter exceeding 15 cm and presented multifocal lesions.

2. **Treatment Challenges**: Due to the tumor's large size, it did not meet the Milan criteria, making the patient ineligible for deceased donor liver transplantation. Additionally, the tumor could not be surgically resected.

3. **Solution**: The patient's identical twin sister served as a living donor, donating her left hemiliver. After approval from the ethics committee and preoperative evaluation, a living donor liver transplantation (LDLT) was performed.

4. **Postoperative Outcome**: More than 8 years post-surgery, both the patient and the donor are in good health, with the patient even having another child. This indicates that in certain cases, even large tumors exceeding the Milan criteria can be cured through living donor liver transplantation.

5. **Research Significance**: This case demonstrates that in specific situations, even large HCCs exceeding standard criteria can be effectively treated through living donor liver transplantation, provided that careful evaluation of the donor and recipient's health is conducted. Future research should focus on optimizing recipient selection criteria to minimize donor risk and improve treatment success rates.